Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma

OBJECTIVE: The present study aimed to explore the correlation of protein kinase D 1 with prognosis in bortezomib-treated multiple myeloma patients and further investigate the effect of protein kinase D 1 knockdown on drug sensitivity to bortezomib in multiple myeloma cells. METHODS: Totally, 104 de...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuesong, Yang, Ying, Yi, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436836/
https://www.ncbi.nlm.nih.gov/pubmed/32799769
http://dx.doi.org/10.1177/1533033820936770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436836/
https://www.ncbi.nlm.nih.gov/pubmed/32799769
http://dx.doi.org/10.1177/1533033820936770

Ejemplares similares